发明名称 SUTAINED RELEASE FORMULATION FOR VENLAFAXINE HYDROCHLORIDE
摘要 The invention provides a sustained release composition that; 1. Is free of initially increased drug delivery that occurs in sustained release systems containing the water soluble drug venlafaxine HCl, known as burst phenomenon, by using a functional core partially or totally coated by a functional coating layer or film. 2. Delivers the drug substance within 24 hours and is therefore suitable for once daily administration of the said drug substance. 3. Exhibits linearity between the strength of the drug formulation and the total mass of the formulation, by proportional increase of the amounts of the drug substance and the excipients in the formulation. 4. Is possible to be divided in smaller doses, without affecting the release of the drug substance. <??>The invention provides a sustained release capsule formulation containing an appropriate number of functional complex mini tablets comprising of: 1. A functional core comprising the active ingredient, especially the water-soluble drug Venlafaxine HCl and appropriate excipients. 2. A functional coating layer or film that reduces the initial surface of the core that is available for the release of the water-soluble drug Venlafaxine HCl, reducing the burst phenomenon.
申请公布号 PL207998(B1) 申请公布日期 2011.02.28
申请号 PL20040379465 申请日期 2004.07.23
申请人 PHARMATHEN S.A. 发明人 KARAVAS EVANGELOS;LIOUMIS KONSTANTINOS;POLITIS STAVROS
分类号 A61K9/48;A61K9/52;A61K31/137 主分类号 A61K9/48
代理机构 代理人
主权项
地址